Effect of intra-uterine hCG injection versus placebo in improving implantation in women fertilized with IVF method

Effect of intra-uterine hCG injection versus placebo in improving implantation in women fertilized with IVF method: a randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201510079014N81

Enrollment

Registered

2015-10-20

Start date

2015-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intra-uterine hCG injection 500 U single dose. Intervention 2: Without injection.

Treatment - Drugs

Intra-uterine hCG injection 500 U single dose

Without injection

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age of 18 to 40 years; the cause of infertility is male sex. Exclusion criteria: using OCP or any kind of hormonal products before IVF; azoospermia; having myoma or history of myomectomy; endometriosis.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Assessing pregnancy. Timepoint: 2 weeks after intervention. Method of measurement: using pregnancy test.;Assessing pregnancy sock. Timepoint: 3 weeks after intervention. Method of measurement: using ultrasonography.	—

Secondary

Measure	Time frame
Assessing abortion. Timepoint: before 20 weeks of pregnancy. Method of measurement: with taking history.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sima Saffary

Fatemieh Hospital

simasaffary@yahoo.com+98 81 3828 3939

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026